Therapeutic effect of β-tricalcium phosphate in mastoid cavity obliterationunder endoscope
-
摘要: 目的 探讨耳内镜术中使用β-磷酸三钙填塞乳突术腔的治疗效果。方法 将2021年9月至2022年3月收治的中耳胆脂瘤患者60例纳入研究。观察组30例,术中填塞β-磷酸三钙;对照组30例,术中填塞自体组织。2组患者术前、术后行纯音听阈测听,记录500、1 000、2 000、4 000 Hz气导阈值;测量术中乳突填塞完成后及术后外耳道口内1 cm处横截面积。比较2组患者术后干耳时间、听力改变情况、乳突术腔愈合情况差异。结果 观察组患者术后干耳时间为4~14周,平均(9.4±2.7)周;对照组患者术后干耳时间为4~26周,平均(16.0±5.7)周;2组干耳时间差异有统计学意义(P < 0.05)。观察组气导听阈较术前改变值为-19~27 dB,平均(6.4±10.7) dB;对照组气导听阈较术前改变值为-9~17 dB,平均(4.7±7.1) dB;2组听力改变差异无统计学意义(P>0.05)。观察组术后外耳道口内1 cm处面积较术中改变值为-5.9~8.2 mm2,平均为(-0.6±2.6) mm2;对照组术后外耳道口内1 cm处面积较术中改变值为-5.5~5.2 mm2,平均为(-0.4±2.3) mm2;2组术腔改变差异无统计学意义(P>0.05)。结论 内镜中耳胆脂瘤术中应用β-磷酸三钙填塞乳突术腔对患者听力无不良影响,可缩短术后干耳时间,患者术后愈合良好,值得推广。Abstract: Objective To investigate the therapeutic effect of β-tricalcium phosphate in mastoid cavity obliteration for middle ear cholesteatoma under endoscope.Methods Sixty patients with middle ear cholesteatoma admitted to our department from September 2021 to March 2022 were included in this study. The observation group(n=30) received β-tricalcium phosphate during mastoid cavity obliteration. The control group(n=30) received autologous tissue during mastoid cavity obliteration. Pure tone audiometry was performed before surgery and after surgery in both groups, and the air conduction thresholds of 500, 1 000, 2 000 and 4 000 Hz were recorded. The external acoustic meatus cross-sectional area within 1 cm of the external acoustic meatus opening was measured during the operation and after the operation. The differences of postoperative ear drying time, hearing change and mastoid cavity healing were compared between the two groups.Results The duration of postoperative dry ear in the observation group was 2-14 weeks, with an average of (9.4±2.7) weeks, while that in the control group was 4-26 weeks, with an average of(16.0±5.7) weeks. The difference in dry ear time between the two groups was statistically significant(P < 0.05). In the observation group, the threshold change was -19-27 dB, with an average of(6.4±10.7) dB, and in the control group, the threshold change was -9-17 dB, with an average of (4.7±7.1) dB. There was no significant difference in hearing change between the two groups(P>0.05). In the observation group, the cross-sectional area of 1 cm inside the ear canal opening was -5.9-8.2 mm2, with an average of (-0.6±2.6) mm2, and in the control group, the cross-sectional area of 1 cm inside the ear canal opening was -5.5-5.2 mm2, with an average of (-0.4±2.3) mm2. There was no significant difference in intraoperative cavity changes between the two groups(P>0.05).Conclusion The application of β-tricalcium phosphate to fill the mastoid cavity during the operation of endoscopic middle ear cholesteatoma has no adverse effect on the hearing of patients, can shorten the postoperative dry ear time, and results in good postoperative healing, which is worth promoting.
-
Key words:
- endoscope /
- cholesteatoma of middle ear /
- mastoid /
- β-tricalcium phosphate
-
-
表 1 观察组和对照组一般资料比较
组别 性别/例 年龄/岁 病程/月 患侧/例 ETDQ-7评分/例 男 女 左 右 ≤14 >14 观察组 11 19 39.7±17.9 44.1±76.7 12 18 7 23 对照组 12 18 44.1±17.8 26.8±56.2 13 17 5 25 P 0.79 0.53 0.13 0.79 0.52 表 2 观察组和对照组术后听力改变情况比较
dB, X±S 组别 术前气导听阈 术后气导听阈 气导听阈改变 观察组(n=30) 48.3±17.4 43.4±19.2 6.4±10.7 对照组(n=30) 54.8±19.0 49.8±21.0 4.7±7.1 P 0.42 0.84 0.07 表 3 观察组和对照组术腔横截面积改变值比较
mm2, X±S 组别 术中外耳道横截面积 术后外耳道横截面积 外耳道横截面积改变值 观察组(n=30) 53.8~82.6 40.7~70.2 -0.6±2.6 对照组(n=30) 55.5~80.9 46.6~80.1 -0.4±2.3 P 0.49 -
[1] 廖天义, 刘海森, 周轶, 等. 扩大面隐窝入路完壁式乳突根治术治疗在中耳胆脂瘤的临床应用分析[J]. 中国中西医结合耳鼻咽喉科杂志, 2022, 30(4): 258-261, 293. https://www.cnki.com.cn/Article/CJFDTOTAL-XYJH202204005.htm
[2] 徐继峰, 蒋雯, 刘洁, 等. 宽频声导抗在中耳胆脂瘤与慢性化脓性中耳炎鉴别诊断中的价值[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(5): 376-381. doi: 10.13201/j.issn.2096-7993.2022.05.011
[3] 董吕华, 毛华杰, 赵波. 耳后带蒂肌骨膜瓣及自体骨粉在开放式乳突根治术腔填塞术中的应用研究[J]. 中国耳鼻咽喉头颈外科, 2017, 24(8): 427-428, 430. https://www.cnki.com.cn/Article/CJFDTOTAL-EBYT201708016.htm
[4] 曲亚明. 内镜下中耳胆脂瘤手术路径探索[J]. 中国内镜杂志, 2021, 27(9): 61-68. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGNJ202109011.htm
[5] 廖华, 虞幼军, 侯昭晖. 持续灌流模式下的耳内镜外科手术[J]. 中华耳科学杂志, 2021, 19(2): 192-197. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHER202102002.htm
[6] 曹中伟. 乳突根治术应用骨水泥填塞乳突腔的临床观察[J]. 中国社区医师(医学专业), 2012, 14(14): 179-179. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSQ201214171.htm
[7] 韩在文, 刘清明, 张玉莉, 等. 同种异体骨乳突填塞术治疗慢性中耳乳突炎远期疗效分析[J]. 潍坊医学院学报, 1993, 15(3): 214-215. https://www.cnki.com.cn/Article/CJFDTOTAL-MAKE199303021.htm
[8] Mahendran S, Yung MW. Mastoid obliteration with hydroxyapatite cement: the Ipswich experience[J]. Otol Neurotol, 2004, 25(1): 19-21.
[9] Minoda R, Hayashida M, Masuda M, et al. Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy[J]. Otol Neurotol, 2007, 28(8): 1018-1021.
[10] Weiss NM, Stecher S, Bächinger D, et al. Open mastoid cavity obliteration with a high-porosity hydroxyapatite ceramic leads to high rate of revision surgery and insufficient cavity obliteration[J]. Otol Neurotol, 2020, 41(1): e55-e63.
[11] McCoul ED, Anand VK, Christos PJ. Validating the clinical assessment of eustachian tube dysfunction: The Eustachian Tube Dysfunction Questionnaire(ETDQ-7)[J]. Laryngoscope, 2012, 122(5): 1137-1141.
[12] 杨海弟, 高敏倩, 熊浩, 等. 耳内镜下中耳手术及鼓室成形术效果分析[J]. 中华耳科学杂志, 2017, 15(4): 403-407. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHER201704004.htm
[13] 杨仕明, 侯昭晖. 耳内镜侧颅底外科的现状和未来[J]. 中华耳科学杂志, 2019, 17(3): 280-283. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHER201903001.htm
[14] Marchioni D, Molteni G, Presutti L. Endoscopic anatomy of the middle ear[J]. Indian J Otolaryngol Head Neck Surg, 2011, 63(2): 101-113.
[15] Stern Shavit S, Sharma RK, Chern A, et al. Pearls and pitfalls in endoscopic ear surgery[J]. Otolaryngol Clin North Am, 2021, 54(1): 201-209.
[16] Kozin ED, Lehmann A, Carter M, et al. Thermal effects of endoscopy in a human temporal bone model: implications for endoscopic ear surgery[J]. Laryngoscope, 2014, 124(8): E332-E339.
[17] Hu S, Li CM, Zhang SY, et al. Clinical value of oral repair membrane and β-tricalcium phosphate in the treatment of the postoperative bone defect of jaw cyst[J]. West China J Stomatol, 2020, 38(5): 541-545.
[18] Liang D, Pei J, Zhang L, et al. Treatment of pre-collapse non-traumatic osteonecrosis of the femoral head through Orthopdische Chirurgie München approach combined with autologous bone mixed with β-tricalcium phosphate porous bioceramic bone graft: a retrospective study of mid-term results[J]. J Orthop Surg Res, 2021, 16(1): 492.
[19] Rolvien T, Barvencik F, Klatte TO, et al. β-TCP bone substitutes in tibial plateau depression fractures[J]. Knee, 2017, 24(5): 1138-1145.
[20] Lee HB, Lim HJ, Cho M, et al. Clinical significance of β-tricalcium phosphate and polyphosphate for mastoid cavity obliteration during middle ear surgery: human and animal study[J]. Clin Exp Otorhinolaryngol, 2013, 6(3): 127-134.
-